Author: Wang, Kai; Ran, Ling; Yan, Tao; Niu, Zheng; Kan, Zifei; Zhang, Yiling; Yang, Yang; Xie, Luyi; Huang, Shilei; Yu, Qiuhan; Wu, Di; Song, Zhenhui
Title: Anti-TGEV Miller Strain Infection Effect of Lactobacillus plantarum Supernatant Based on the JAK-STAT1 Signaling Pathway Document date: 2019_11_6
ID: 05tf6oqa_17
Snippet: IPEC-J2 cells were inoculated into 6-well plates at 1.8 × 10 6 /mL. When they reached 90% confluence, three experimental groups were established: An Lp-1s optimal concentration treatment group infected TGEV, a TGEV single infection group, and the uninfected control group. Cell samples at 6, 12, 24, and 48 hpi were centrifuged at 4000 rpm for 10 min, and the supernatant subjected to an enzyme linked immunosorbent assay (ELISA) to detect IFN-β......
Document: IPEC-J2 cells were inoculated into 6-well plates at 1.8 × 10 6 /mL. When they reached 90% confluence, three experimental groups were established: An Lp-1s optimal concentration treatment group infected TGEV, a TGEV single infection group, and the uninfected control group. Cell samples at 6, 12, 24, and 48 hpi were centrifuged at 4000 rpm for 10 min, and the supernatant subjected to an enzyme linked immunosorbent assay (ELISA) to detect IFN-β.
Search related documents:
Co phrase search for related documents- cell sample and ELISA immunosorbent assay: 1, 2
- cell sample and immunosorbent assay: 1, 2
- cell sample and treatment group: 1
- control group and ELISA immunosorbent assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and ELISA immunosorbent assay link: 1
- control group and experimental group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and immunosorbent assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and optimal concentration: 1, 2, 3
- control group and optimal concentration treatment group: 1
- control group and single infection: 1, 2, 3, 4, 5, 6, 7, 8
- control group and single infection group: 1, 2
- control group and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and uninfected control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- ELISA immunosorbent assay and experimental group: 1, 2
- ELISA immunosorbent assay and immunosorbent assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ELISA immunosorbent assay and optimal concentration: 1, 2
- ELISA immunosorbent assay and single infection: 1
- ELISA immunosorbent assay and treatment group: 1, 2, 3, 4, 5, 6
- ELISA immunosorbent assay link and immunosorbent assay: 1
Co phrase search for related documents, hyperlinks ordered by date